Uridine 5'-triphosphate Terminated Phase 2 Trials for Interstitial Lung Diseases (ILD)

IndicationsStatusPurposePhase
TerminatedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT01381666Evaluation of the Diagnostic Utility of INS316 in Patients With Interstitial Lung Diseases (01-701)